Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
British Journal of Pharmacology|June 27, 2007
Differential regulation of Akt, caspases and MAP kinases underlies smooth muscle cell apoptosis during aortic remodelling in SHR treated with amlodipineD Duguay, D deBloisEuropean Journal of Pharmacology|October 6, 1987
The ability of des-Arg9-bradykinin to relax rabbit isolated mesenteric arteries is acquired during in vitro incubationD Deblois, F MarceauThe Canadian Journal of Cardiology|May 31, 2001
Endothelial and myocyte apoptosis--role of angiotensin IIP Hamet, D deBloisClinical Nursing Research|February 1, 1995
Postpartum early discharge: impact on maternal fatigue and functional abilityC Smith-Hanrahan, D DebloisBritish Journal of Pharmacology|January 13, 2001
Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effectsD deBlois, R A HorlickJournal of the Renin-Angiotensin-Aldosterone System : JRAAS|April 23, 2002
Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after injuryJ Lemay, P Hamet, D deBloisBritish Journal of Pharmacology|May 1, 1991
Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1D deBlois, J Bouthillier, F MarceauLife Sciences|January 1, 1990
Bacitracin U.S.P. contains a factor that stimulates receptors for 5-hydroxytryptamine on rabbit aortic stripsD deBlois, J Bouthillier, F MarceauBritish Journal of Pharmacology|October 1, 1987
Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivoJ Bouthillier, D Deblois, F MarceauImmunopharmacology|May 1, 1989
Pharmacological modulation of the up-regulated responses to des-Arg9-bradykinin in vivo and in vitroD deBlois, J Bouthillier, F MarceauPageof 4